SC 13G/A: Kiniksa Pharmaceuticals, Ltd.
Ticker: KNSA · Form: SC 13G/A · Filed: Apr 5, 2024 · CIK: 1730430
| Field | Detail |
|---|---|
| Company | Kiniksa Pharmaceuticals, LTD. (KNSA) |
| Form Type | SC 13G/A |
| Filed Date | Apr 5, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Kiniksa Pharmaceuticals, Ltd..
Risk Assessment
Risk Level: low
FAQ
What type of filing is this?
This is a SC 13G/A filing submitted by Kiniksa Pharmaceuticals, LTD. (ticker: KNSA) to the SEC on Apr 5, 2024.
What is the risk level of this SC 13G/A filing?
This filing has been assessed as low risk.
Where can I view the full SC 13G/A filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on April 5, 2024 regarding Kiniksa Pharmaceuticals, Ltd. (KNSA).